chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash all over face and right arm; Face looked red; Really bad headache; Flu-like symptoms; Upset stomach; Temperature of 102.5F/ lower temperature in the 100s/ low fever; Felt real achy; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), ABDOMINAL DISCOMFORT (Upset stomach), ERYTHEMA (Face looked red), RASH (Rash all over face and right arm) and PYREXIA (Temperature of 102.5F/ lower temperature in the 100s/ low fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), ABDOMINAL DISCOMFORT (Upset stomach), PYREXIA (Temperature of 102.5F/ lower temperature in the 100s/ low fever), PAIN (Felt real achy) and CHILLS (Chills). On 04-Apr-2021, the patient experienced ERYTHEMA (Face looked red) and HEADACHE (Really bad headache). On 05-Apr-2021, the patient experienced RASH (Rash all over face and right arm). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), ABDOMINAL DISCOMFORT (Upset stomach), ERYTHEMA (Face looked red), RASH (Rash all over face and right arm), PYREXIA (Temperature of 102.5F/ lower temperature in the 100s/ low fever), PAIN (Felt real achy), CHILLS (Chills) and HEADACHE (Really bad headache) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Apr-2021, Body temperature: 102.5 (Inconclusive) 102.5 F. On 03-Apr-2021, Body temperature: 100 (Low) 100s.         Concomitant product use was not provided.      Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow-up information received contains updated information of outcome of the events, updated from unknown to recovered.
Patient received influenza vaccine on 10/11/2008. (Fluzone)  Had bruising at injection site.  On 10/16/2008 came to store.  Bruise was about 2.5 inches in diameter and a small bump could be palpated at site.  Bruising had begun to resolve and the edges were yellow, to yellow-green. Bruise was not warmer than the surrounding skin.  Patient also complained of soreness in tricep.
I woke up on 10/18/2022, and my right arm, through my fingers was tingling like it was asleep. That continued through the day and my arm felt heavy. I went to the chiropractor who ensured that everything was in alignment, but nothing changed. They advised that I report it if it did not get better the next day. It is still tingling in my fingers now, and it is worse when I sleep.
OFF LABEL USE; INAPPROPRIATE SCHEDULE OF VACCINE ADMINISTERED; This spontaneous report received from a health care professional concerned a 67 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received one dose Moderna covid-19 vaccine (spikevax, elasomeran) (Dose number in series 1) (forms of admin, route of admin not reported, batch number: Unknown, expiry: Unknown) dose was not reported, administered on an unspecified date for prophylactic vaccination. The patient had an allergic reaction with first dose of moderna covid-19 vaccine (spikevax, elasomeran) and did not complete the series due that (Dose number in series 1).  The patient received first covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) dose was not reported, 1 total administered on 09-MAY-2021 for prophylactic vaccination because patient was unable to take Moderna, which was an off label use as inappropriate schedule of vaccine administered (Dose number in series 2). The batch number was not reported and has been requested. Age at time of vaccination 67 years old. No concomitant medications were reported. The patient also received additional second covid-19 vaccine ad26.cov2.s (Dose number in series 3) (suspension for injection, route of admin not reported, batch number:1882809, expiry: Unknown) dose was not reported, 1 total administered on 12-NOV-2021 for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with second covid-19 vaccine ad26. cov2.s (Dose number in series 3). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the off label use and inappropriate schedule of vaccine administered was not reported. This report was non-serious.
Pregnancy began failing around 9/26/2021 (around 6 weeks) according to bloodwork, cramping pain,  miscarriage on 9/29/2021.
6-18-07 loss of appetite, listless and lethargic at daycare-notified mom. 6-20-07 pustules observed on trunk. Saw Dr who dx chickenpox
Patient needed influenza vaccine. I checked the 2014 Recommended Immunization Schedules for Persons Aged 0 through 18 years under to verify that the patient would need 2 vaccines because he had never had one before. I found #8 Influenza Vaccine and dropped down to the section for children aged 6 months to 8 years. Because I was looking for that specific information, I did not read the section that told the minimum age for the live virus. When I got the vaccine out of the box, there was not an age range on it as there is on the FLUZONE boxes. I had never been told the minimum age is 2 years and only discovered this when I received a fax from an insurance company that had the information on it. I reported to the state as soon as I discovered it and they contacted the manufacturer and found out that it is a valid dose event tho they do not recommend it for under age 2 years.
Took Covid shot March 6 (J&J). Since then has felt fatigued and achy. No fever but has had joint pains. Feels SOB with walking. Feels it is worse since the shot. Having pain in the back of the neck, and her hands and knees are swollen (but not red or hot). Feels this is worse than it was before. Taking furosemide but swelling not going away. Taking spironolactone and potassium. Takes furosemide 4 days a week. No N, V, but has had diarrhea since taking vaccine.  She says her husband has had very similar symptoms.
9SEP96 per MD pt called w/fever up to 103, MD advised return to clinic; pt also recovering from OM;
On August 29, 2022, I took an at home COVID-19 test and tested positive. I contacted my doctor, and they could not prescribe me PAXLOVID due to my other prescribed medication. I went in for a doctor's visit and they prescribed me an antibiotic, but I don't recall the name.
Wed. nite started with headache. Thursday headache was gone. Thursday, lethargic, nausea. Friday, morning face to abdomen had blotchy rash. Saturday, resolved.
Information has been received from a consumer concerning her son who, "as an infant", was vaccinated with a dose of ROTATEQ.  Subsequently the patient experienced diarrhea.  Subsequently, the patient recovered.  The patient also experienced mild symptoms of autism while on therapy with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (+) rubella virus vaccine live (Wistar RA 27/3) (MSD, WAES 0902USA03761).  Additional information is not expected.
Chest pains, irregular heartbeat, chills, cold hands, nauseous, light headed/fainting, sweats
Cardiac failure congestive; shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 72 years old male patient. No information was provided regarding concomitant medications, concurrent conditions or medical history. On an unknown day in June 2015, the patient was vaccinated for prophylaxis with zoster vaccine live (ZOSTAVAX) for prophylaxis (dose, route, anatomical location, lot number and expiration date were not provided) at his physician's Office. On an unknown date (also reported as 08-JUN-2012, conflicting information due to onset date of the adverse event was reported prior vaccination date), the patient experienced herpes zoster (shingles) and cardiac failure congestive. As a result of the zoster Vaccine Live (ZOSTAVAX) vaccination, the patient's symptoms have resulted in severe pain, suffering, and emotional distress, as well as to incur substantial economic damages. In addition, the patient sustained severe and permanent personal injuries. The outcome of the events of cardiac failure congestive and shingles was considered as not recovered. The reporter considered the events to be related to zoster Vaccine Live (ZOSTAVAX).   Upon internal review, the event of cardiac failure congestive was determined to be medically significant. The events of cardiac failure congestive and shingles were considered to be disabling.
Headaches; Dizziness; Fatigue; Sweating; Chills; Joint pain; Body aches; Sore throat; Coughing; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8839) via an unspecified route of administration in the right arm on 06Oct2021 at 09:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic and osteoarthritis, spondylosis, migraines. Prior to vaccination, the patient was not diagnosed with COVID -19. Concomitant medications included trazodone hydrochloride (DEPRAX) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA8780) via an unspecified route of administration in the right arm on 15Sep2021 at 09:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient previously also received pneumococcal 13 valent vaccine (PVC-13 PNEUMONIA VACCINE) for unknown indication from an unknown date and experienced allergy to vaccine and triamcinolone acetonide (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and experienced drug allergy. On 06Oct2021 at 23:00, the patient experienced chills, joint pain, body aches, sore throat and coughing. On 07Oct2021 at 22:00, the patient experienced sweating. On 08Oct2021 at 21:00, the patient experienced headaches, dizziness and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events chills, joint pain, body aches, sore throat and coughing was resolved on 07Oct2021 at 19:00, sweating was resolved on 08Oct2021 at 21:00 while headaches, dizziness and fatigue was resolved on 15Oct2021 at 08:00.
I had a little pain in my arm  at the injection site.  I tested positive with a home test for COVID-19 on 09/14/2022.  We had attended a couple of family events at which time I believe I got exposed to the virus. I had head congestion, sore throat for half a day and tired.  I contacted my doctor on 09/14/2022 for the prescription for Paxlovid.
Outbreak of Shingles; 3 outbreaks of genital herpes; This is a spontaneous report from a contactable consumer. A 62-year-old non-pregnant female patient received BNT162B2, via an unspecified route of administration, administered in left arm on 18Mar2021 01:30 (Batch/Lot Number: EN6207) at single dose, dose 2 via an unspecified route of administration, administered in right arm on 09Apr2021 01:30 (Batch/Lot Number: EW0158) at single dose for covid-19 immunisation. The patient's medical history and concomitant medications was not reported. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24May2021 patient had an outbreak of Shingles. She had Shingrix shots on Sep. 14 and Nov 13 2020. She also on a suppressive dose 1g per day of Valacyclovir and the Shingles still broke through. She filed another report on approx May 14 stating that she had had 3 outbreaks of genital herpes in a 6 week period beginning on the week after first shot. The patient was getting very concerned about this. The adverse event result in doctor or other healthcare professional office/clinic visit. The treatment received for the adverse event was 1 gm Valacyclovir per day. The outcome of the events was not recovered.  Follow-up attempts are needed. Further information is requested.
Woke up morning after vaccination with a black phlegm in the back of my throat.  No phlegm in nose or lungs, just in throat.  No other symptoms.
Information has been received from an RN concerning a 72 year old male with a history of pneumococcal vaccine 23 (MSD) 10-15 years ago who on 10/31/01 was vaccinated with pneumococcal vaccine 23 polyvalent, .5cc IM, in the right tricep (lot 636158/1456K). That night, the pt experienced pain and developed inflammation, redness and swelling at the injection site and was unable to raise his arm. The nurse reported that the pt treated the area with an ice pack 20 minutes on and 20 minutes off. On 11/1/01, the pt noted fluid bubbles on his right upper arm. The pt was seen at the ER the next day and the fluid bubble had extended to his elbow. The pt was dx'd with cellulitis and therapy with cephalexin (Keflex) was started. The pt was treated as an outpatient, never hospitalized. On 11/9/01, the pt's sister reported to the RN that the pt's cellulitis was resolving well. The nurse reported that the pt's sister and 2 other consumers received pneumococcal vaccine 23 polyvalent at the same location on the same day and experienced pain at the injection site (WAES01110493 and WAES01111426) (lot 636158/1456K). The reporting RN felt that cellulitis, pain, redness and swelling were considered "Other Important Medical Events". In follow up information received the registered nurse reported that the patient was recovered from cellulitis, pain, redness, swelling, weakness and injection site inflammation. The nurse reported conflicting information that the pt received therapy with pneumococcal vaccine 23 polyvalent on 10/23/01. The reporter expressed that the patient stated that he was concerned about the lot. The records of testing prior to release of this lot have been checked and found to be satisfactory. The lot complies with the standards and was released. No further information is available.
Several days after injection:  arm pain, large pink rash, warm, itchy at arm site.  Dr. looked at it on 03/22/2021 and didn?t believe it was cellulitis.  4-5 days later, no symptoms
Severe shoulder pain with severe restricted movement of entire arm. This was the arm in which the pneumonia vaccine was administered.
pt recvd vax; intermittant ha, n, general malaise; took apap & advil & ha resolved but worse ha pt ever had;12aug93 f/u:no addtl event info provided other than above; recvd addtl pt info;
Extreme muscle soreness in R arm at injection site. Low grade fever, body aches, chills, started next day. Subsided saturday night.
Day after vaccines arm sore, warm to touch and painful to touch.  01/07/2021 Right now on and off Headaches and nauseas for a long period of time. this starts on 1/15/2021
This case was reported by a healthcare professional and described the occurrence of fever in a 4-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline).  On 22 September 2009 the subject received a dose of FLUARIX (unknown, unknown arm) and drug use for unapproved indication.  On 23 September 2009, one day after vaccination with FLUARIX, the subject experienced fever.  FLUARIX was administered to a 4-year old subject on 22 September 2009.  On 23 September 2009, she experienced a mild fever.  At the time of reporting the outcome of the fever was unspecified.
Hematomas on my tongue. I first started getting oral hematomas in 2003 subsequent to several vaccination and medical errors; for example, there were dosage errors in the Anthrax and Pneumovax vaccine administered to me. Also in 2003, I was given the wrong dosage for the malaria medication Lariam (once daily instead of once weekly). I also have photographs I took of my hematomas after the J& J vaccine. Also, I had no outbreak of hematomas between 2016 and and my J&J vaccine in 2021 after I started supplementing with vitamin D3/K2. However, these hematomas came back after receiving the J&J vaccine, and also after getting the Moderna jab in December 2021. Consequently, I have not had a COVID vaccine since December 2021.
Patient had two vaccines 9AM 10/2/20.  By 4 PM he had chills and felt tired.  By 6PM he went to bed.  At 9PM he remained awake and had excruciating polyarthritis that nearly took him to the hospital.  He also had burning scalp paresthesias.  He took a couple Tylenol and the symptoms resolved over 3 hours.  He has never responded to influenza vaccine in the past so felt it must be the Shingrix.  He's reported symptoms to me because he's afraid it could be worse if he gets a Shingrix booster as he is suppose to in 2-6 months.
It started with severe back pain the day following my injection. I began taking Tylenol. Still wasn?t feeling quite right, and I started to run a fever on Monday evening 8/2/21. I was out of work 8/2/21 and 8/3/21 with fever and body aches. Went to medical facility on 8/3/21 was Covid tested and advised that my symptoms were a ?normal? reaction to vaccine. Returned to work on 8/4/21 with persistent low back pain and pelvic pain. Began having difficulty with urination on 8/7/21. At that same time became extremely constipated. Went back to medical facility on 8/8/21, was advised of trace blood and trace leukocytes in my urine. Was told that it wasn?t enough to treat. Went to work on 8/9/21, I advised doctor, who I work for and she is my gynecologist, that I had not urinated since 8/8/21 and something was not right. She placed a catheter and removed over 800 cc of urine from my bladder. Urine dip did now show any signs of infection.  Urine culture was sent to lab. Was sent home from work with Bactrim DS. Was still unable to urinate on my own at 4:00pm. Was advised to go to ER. Waited 3 hours at medical facility and couldn?t wait anymore. Went to another medical facility on 8/9/21. Foley catheter was placed, blood drawn, and X-rays taken. Was sent home with Foley catheter in place. Saw a doctor on 8/10/21 and diagnosed with neurogenic bladder.
I experienced a breakthrough case of COVID-19 with soreness in my shoulder, sinus pain, watery eyes, sore throat and body aches.
NIGHT OF VAX, PT EXP ITCHING ALL OVER, AND RASH COVERED BODY. TREATED WITH SELDANE AND RECOVERED BY NEXT MORNING.
4/6/22 G2P1001 at 39w6d by 8wk who presents to triage for contractions q5-7 that started getting more uncomfortable within the last two hours.
Saturday - pain at injection site. Saturday evening - shivering, aching joints. Sunday - achy, tired, beginning of swollen armpit region (gland?). Monday - swollen armpit region. Tuesday - attempted to follow up with patient, but unable to reach him.
right thigh swelling from hip to knee starting about 12 hrs after DTap given in that thigh.  No redness, tenderness, rash, fever.  FROM at hip and knee.  Slight limp when walking but pt able to jump up and down. No treatment given/needed.
Patient experienced headache, arm soreness, rash beneath injection site (not at actual injection site).
finished / second injection in January developed another serious case in the last two weeks; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of herpes zoster (For the tolerability of 1st dose, refer case US2021AMR041318 reported for same patient.).   In January 2020, the patient received the 2nd dose of Shingles vaccine. In January 2021, less than a month after receiving Shingles vaccine, the patient experienced shingles (serious criteria other: serious as per reporter). On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported The age group was not reported but was captured as adult as per vaccine indication.  It was reported that patient finished the second injection of the vaccine in January and developed another serious case in the last two weeks. The patient mentioned that because of that patient did not do vaccines, patient also stated that would not getting the Covid vaccine.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR041318:same reporter
Received flu vaccine on Fri 10/24/03 and c/o Sat with flu-like symptoms and Sunday developed a rash, felt like pins and needles coming out of her arms.
This case was reported by a pharmacist via other manufacturer and described the occurrence of cellulitis in a patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced cellulitis (serious criteria GSK medically significant). On an unknown date, the outcome of the cellulitis was unknown. It was unknown if the reporter considered the cellulitis to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was captured as adult as per vaccine indication.
Client called in on 1/13/2021 and spoke with an immunization RN  and complained of a rash down her right arm and on her back.  The RN advised her go to her PCP for evaluation, take OTC Benadryl and pain medication in the meantime.  The client explained that she was going to the urgent care center and that she would call us back.  The client came into the office on 1/14/2021 and spoke with RN  at the office.  The urgent care  center didn't give the client a diagnosis per client and that they just told her to keep it covered and not to itch it.  They client complained that it itched and was painful with burning.  I looked at the rash and the rash was in patches of raised bumps going down her right arm and the client said that it was  on her back as well.  The rash appeared to look as though it was shingles.  I advised the client to have a PCP evaluate her.  I gave her a number and location to go as well as a referral to be seen.  I advised the client to speak with the PCP about her 2nd doses of vaccine as well as  an possible work excuse.
Flu vaccine given on 10/16/17 at approx 4 PM. She states she woke up at approximately 4 AM the next morning with hives over her whole body. She was rx with Medrol Pac. Symptoms resolved after treatment.
Around 24 hours after the vaccine was administered, my right upper arm became red, swollen and warm to the touch.
Soreness x 2 days after Pneumococcal injection on right side of neck down to right arm deltoid area.
Information has been received from a nurse practitioner referring to a 69 years old female patient. The patient received doses of PNEUMOVAX 23 (lot # K021030, expiration June 2016, dose was not reported) on the following dates: 16-SEP-2015 and 19-NOV-2015 (inappropriate schedule of vaccine administration). No adverse experience was reported. Additional information has been requested.
Pt had previously received a TDAP 5/20/10 & was recorded on a separate IZ record. Original IZ record didn't have date recorded. Pt was then given a TDAP with assumption she had not rcd. one in past.